English
Español
Ultrasound laparoscopy
The association of ultrasound and laparoscopy represents an excellent diagnostic alternative for a deep surface study of digestive viscera.
The main aim of ultrasound laparoscopy is detecting local or spread advanced illnesses that have not been detected yet in the radiologic or endoscopic explorations due to their reduced size or complex localization.
The most usual prescriptions that our Department advices for digestive apparatus tumors are the following:
Esophagus/Stomach
- Presurgical staging of esophageal-gastric carcinoma
- Evaluation after chemoradiotherapy. (post- chemoradiotherapy evaluation)
- Perigastric and periesophagic biopsies of celiac trunk adenopathy
- Peritoneal biopsies
- Liver metastasis detection
Pancreas/Billiary tree
- Presurgical staging of bilio-pancreatic tumors
- Evaluation after chemoradiotherapy (post- chemoradiotherapy evaluation)
- Biopsy of local and regional adenopathies
- Localization of small pancreatic tumors of neuroendocrine lineage
- Biopsy of pancreatic mass
- Liver metastasis detection
- Choledocolithiasis detection during laparotomic cholecystectomy
Liver
- Presurgical staging of liver tumors
- Location of the number, size and vascular-biliary connections of primary and secondary liver tumors
- Evaluation after chemotherapy
- Assesment of portal hypertension degree
- Biopsy of local and regional adenopathies
- Biopsy of liver tumors
- Biopsy of liver parenchyma
Colon-Rectum
- Colorectal carcinoma presurgical staging
- Evaluation after surgical treatment or chemoradiotherapy
- Evaluation of peritoneal relapses
- Biopsy of adenopathies and perirectal mass
- Peritoneal biopsies
- Hepatic metastasis detection
Extradigestive pathology
- Presurgical staging of extradigestive carcinoma suspected of being diseminated in the peritoneum and/or affecting the lymphatic glands
- Biopsy of adenopathies of unknown origin
- Evaluation of biopsy of retroperitoneal mass
- Hepatic metastasis detection
Therapeutic laparoscopic ultrasound
- Ethanolization of primary and/or secondary liver tumors
- Radiofrecuency ablative treatment for primary and secondary liver tumors
- Radiofrecuency ablative treatment for primary pancreatic tumors
ADVANTAGES
- It permits a precise individualization of the oncologic treatment in patiens with malignant digestive tumors.
- It performs a precise staging of malignant digestive tumors and ensures the performance of adjuvant and neoadjuvant chemotherapic treatment in patients suspected of having advanced tumors.
- It prevents patients with disseminated processes, from undergoing unnecessary surgery.
- It globally reduces their stay at hospital.
- It reduces expenses which derive from the treatment of patients with digestive tumors.
Clinical Cases:
